Page last updated: 2024-08-23

mifepristone and Placenta Praevia

mifepristone has been researched along with Placenta Praevia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Du, S; Li, R; Long, Q; Tang, F; Wu, S; Zhao, Y1
Chen, S; Hu, Q; Li, C; Li, J; Luo, L; Yang, X; Zhang, X1
Chen, C; Jiang, Y; Lin, F; Wang, X; Wu, S1
Borrás, A; Gómez, O; Martínez, JM; Puerto, B; Sanz, M1

Other Studies

4 other study(ies) available for mifepristone and Placenta Praevia

ArticleYear
The method for termination of mid-trimester pregnancy with placenta previa: A case study.
    Medicine, 2022, Aug-05, Volume: 101, Issue:31

    Topics: Cesarean Section; Ethacridine; Female; Humans; Mifepristone; Misoprostol; Placenta; Placenta Previa; Pregnancy; Retrospective Studies

2022
Clinical analysis of second-trimester pregnancy termination after previous caesarean delivery in 51 patients with placenta previa and placenta accreta spectrum: a retrospective study.
    BMC pregnancy and childbirth, 2021, Aug-18, Volume: 21, Issue:1

    Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Cesarean Section; China; Female; Humans; Hysterotomy; Labor, Induced; Mifepristone; Misoprostol; Placenta Accreta; Placenta Previa; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies; Vaginal Birth after Cesarean; Young Adult

2021
Mifepristone combined with ethacridine lactate for the second-trimester pregnancy termination in women with placenta previa and/or prior cesarean deliveries.
    Archives of gynecology and obstetrics, 2017, Volume: 295, Issue:1

    Topics: Abortion, Induced; Adult; Cesarean Section; Ethacridine; Female; Humans; Mifepristone; Placenta Previa; Pregnancy; Pregnancy Trimester, Second

2017
Feticide followed by mifepristone-misoprostol regimen for midtrimester termination of pregnancy in two cases of complete placenta previa.
    Fetal diagnosis and therapy, 2010, Volume: 28, Issue:2

    Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Administration, Oral; Female; Humans; Mifepristone; Misoprostol; Placenta Previa; Postpartum Hemorrhage; Potassium Chloride; Pregnancy; Pregnancy Trimester, Second

2010